CTIX Stock | News | Quote | Stock Forum | Sunday, November 10,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$CTIX Cellceutix Corp. CTIX Company Overview 

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 1:05:54 PM

Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.83
Previous Close 1.81 Open 1.81
Daily Range 1.85 - 1.81 52wk Range 2.47 - 0.92
Volume 99,934 Dividend N/A
Average Vol (3m) 232,267 Yield N/A
Cellceutix Corp. CTIX
Company Information

100 Cumming Center
Suite 151-B
Beverly, MA 01915

Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com

Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Cellceutix Corp. CTIX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts

Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors

Not Available
Company Notes

Formerly=EconoShare, Inc. until 2-2008
Service Providers

Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States

Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC

Cellceutix Corp. CTIX
CTIX Security Details

Share Structure

Market Value1 $185,779,741 a/o Nov 08, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value  0.0001
Shareholders

Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data

Short Interest 111,185 (14%)
Oct 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

West Coast Stock Transfer Inc.

Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations

Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)

Cellceutix Corp. CTIX Recent News

Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sep 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sep 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sep 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets

1
2
next >

CTIX Cellceutix Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Agents Race: 10M Downloads Spark Competitive Fire

Updated Category News Views 4

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

Continue Reading
King City Gardens Debuts Third Dispensary in Cincinnati

Updated Category News Views 2

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

Continue Reading
AMTD IDEA Group: Expanding Its Global Reach

Updated Category News Views 0

AMTD IDEA's Expansive Global Footprint While the rest of the market whirls, AMTD IDEA Group (NYSE: AMTD) is steadying itself with a comprehensive expansion that, quite frankly, demands a second look. Between weaving global media threads and dipping their toes into every alluring venture space, they've formed a tapestry not many could replicate. With facilities stretching...

Continue Reading
Shadeform Debuts Flex VMs, Revolutionizing GPU Utilization

Updated Category News Views 5

GPU Utilization Gets a New Spin with Flex VMs Folks, listen up: Shadeform just fired up something slick with its new Flex VMs. And, let me tell you, in today's market where GPU capacity is vanishing faster than free hotcakes on a Sunday morning, this might well be a game changer. Shadeform’s the name to remember, teaming up data center veterans with peeps who need to...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 3

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading
Short Term Shop Hits $500M in Airbnb Sales Milestone

Updated Category News Views 7

Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...

Continue Reading
Bryan Cranston Stars in Live Streaming 'A Christmas Carol'

Updated Category News Views 9

Cranston Climbs Into Scrooge's Shoes for a Cause If you think you've got the holiday season all figured out, add this curveball: Bryan Cranston as Ebenezer Scrooge, jawing through "A Christmas Carol" as part of a unique, one-night-only staged reading. And it's not just another star-studded ploy for attention. It's about rallying around a cause bigger than holiday cheer,...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 6

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Prosecco DOC Chef Residency Debriefs on Inaugural Year

Updated Category News Views 0

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

Continue Reading
OSV Talks Launches New Season on Ministry Growth

Updated Category News Views 5

A Fresh Wave of Ideas for Catholic Ministry Some topics never go out of style, and it looks like the crew at OSV is banking on that with their latest salvo of OSV Talks. With themes ranging from peacemaking to AI, they're tossing it all against the spiritual wall, hoping it sticks. The comeback of their video series has that classic 'get your act together' vibe we all...

Continue Reading

Top 5 Most Recently Viewed Articles

Halozyme Enhances Collaboration with argenx for Growth

Updated Category News Views 60

Halozyme Partners with argenx for Expanded Growth Opportunities Halozyme Therapeutics (NASDAQ: HALO) has recently reinforced its position in the biopharmaceutical sector with an expanded collaboration alongside argenx. This strategic move, which involves a total commitment of $30 million through upfront payments for four new targets, promises to open up fresh avenues for...

Continue Reading
Distributed Energy Generation Market to Exceed $924 Billion by 2033

Updated Category News Views 143

Exploring the Future of the Distributed Energy Generation Market As we dive into the evolving landscape of the Distributed Energy Generation market, it becomes clear that this sector is on an exciting trajectory. Analysts estimate that the market will grow from an impressive USD 386.91 billion to USD 924.30 billion over the next several years, achieving a compound annual...

Continue Reading
Exploring How Government Spending Affects GDP Insights

Updated Category News Views 362

U.S. Commerce Secretary Howard Lutnick's Proposal Howard Lutnick, the U.S. Commerce Secretary, has stirred conversations with his proposal to exclude government spending from the gross domestic product (GDP) calculations. This significant change aims to provide clearer insights into economic performance. Understanding the Rationale Behind the Proposal Government Spending:...

Continue Reading
Class Action Alert: Endava plc Investors Take Note Today

Updated Category News Views 89

Important Class Action Update for Endava plc Investors If you've purchased securities from Endava plc (NYSE: DAVA) during the recent class period, it's crucial that you take action right away. This alert is your reminder about some significant developments regarding your investment rights. Class Period Details The active class period for this alert runs from May 23, 2023,...

Continue Reading
Empowering Change: Rockefeller Foundation's New Fellowship Launch

Updated Category News Views 443

Revolutionizing Community Support through Innovation The Rockefeller Foundation is stepping up its commitment to improving the lives of many by launching its U.S.-Focused Big Bets Fellowship. This initiative aims to empower twelve innovators across various states, allowing them to create impactful solutions that promote prosperity, health, and economic investment within...

Continue Reading